AMARIN CORP PLC\UK Increase (Decrease) in Accounts Receivable
AMARIN CORP PLC\UK (AMRN) reported Increase (Decrease) in Accounts Receivable of -$33.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-29
- AMARIN CORP PLC\UK increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$15.13M, a 222.09% decline year-over-year.
- AMARIN CORP PLC\UK increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$18.78M.
- AMARIN CORP PLC\UK increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$477.00K, a 104.95% decline year-over-year.
- AMARIN CORP PLC\UK increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $8.18M.
- AMARIN CORP PLC\UK increase (decrease) in accounts receivable for fiscal 2025 was $4.55M.
- AMARIN CORP PLC\UK increase (decrease) in accounts receivable for fiscal 2024 was -$11.28M, a 538.55% decline from fiscal 2023.
- AMARIN CORP PLC\UK increase (decrease) in accounts receivable for fiscal 2023 was $2.57M.
- AMARIN CORP PLC\UK increase (decrease) in accounts receivable for fiscal 2022 was -$32.66M, a 459.76% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$15.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$33.91M 10-Q · filed 2026-07-29 | -$34.39M derived: sum of 3 quarters · filed 2026-07-29 | -$26.21M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$18.78M 10-Q · filed 2026-04-29 | -$19.26M derived: sum of 2 quarters · filed 2026-04-29 | -$11.08M derived: sum of 3 quarters · filed 2026-04-29 | $1.32M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$477.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $7.70M derived: sum of 2 quarters · filed 2026-03-02 | $20.10M derived: sum of 3 quarters · filed 2026-07-29 | $4.55M 10-K · filed 2026-03-02 |
| 2025-09-30 | $8.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $20.57M derived: sum of 2 quarters · filed 2026-07-29 | $5.03M 10-Q · filed 2025-10-29 | $14.67M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $12.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$3.15M 10-Q · filed 2026-07-29 | $6.49M derived: sum of 3 quarters · filed 2026-07-29 | -$4.56M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$15.54M 10-Q · filed 2026-04-29 | -$5.91M derived: sum of 2 quarters · filed 2026-04-29 | -$16.96M derived: sum of 3 quarters · filed 2026-04-29 | -$9.07M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $9.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$1.41M derived: sum of 2 quarters · filed 2026-03-02 | $6.47M derived: sum of 3 quarters · filed 2026-03-02 | -$11.28M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$11.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$3.16M derived: sum of 2 quarters · filed 2025-10-29 | -$20.92M 10-Q · filed 2025-10-29 | -$9.76M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $7.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$9.87M 10-Q · filed 2025-07-30 | $1.29M derived: sum of 3 quarters · filed 2026-03-02 | $961.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | -$17.76M 10-Q · filed 2025-05-07 | -$6.59M derived: sum of 2 quarters · filed 2026-03-02 | -$6.92M derived: sum of 3 quarters · filed 2026-03-02 | -$17.43M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $11.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $10.83M derived: sum of 2 quarters · filed 2026-03-02 | $327.00K derived: sum of 3 quarters · filed 2026-03-02 | $2.57M 10-K · filed 2026-03-02 |
| 2023-09-30 | -$330.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$10.84M derived: sum of 2 quarters · filed 2024-10-30 | -$8.59M 10-Q · filed 2024-10-30 | -$979.00K derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-06-30 | -$10.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$8.26M 10-Q · filed 2024-07-31 | -$649.00K derived: sum of 3 quarters · filed 2025-03-12 | -$21.21M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-03-31 | $2.25M 10-Q · filed 2024-05-01 | $9.86M derived: sum of 2 quarters · filed 2025-03-12 | -$10.71M derived: sum of 3 quarters · filed 2025-03-12 | $23.00M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | $7.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$12.95M derived: sum of 2 quarters · filed 2025-03-12 | $20.76M derived: sum of 3 quarters · filed 2025-03-12 | -$32.66M 10-K · filed 2025-03-12 |
| 2022-09-30 | -$20.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $13.14M derived: sum of 2 quarters · filed 2023-11-01 | -$40.27M 10-Q · filed 2023-11-01 | -$25.98M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $33.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$19.71M 10-Q · filed 2023-08-02 | -$5.42M derived: sum of 3 quarters · filed 2024-02-29 | -$38.32M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$53.42M 10-Q · filed 2023-05-03 | -$39.13M derived: sum of 2 quarters · filed 2024-02-29 | -$72.03M derived: sum of 3 quarters · filed 2024-02-29 | -$41.04M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $14.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$18.61M derived: sum of 2 quarters · filed 2024-02-29 | $12.38M derived: sum of 3 quarters · filed 2024-02-29 | $9.08M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$32.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$1.91M derived: sum of 2 quarters · filed 2022-10-27 | -$5.21M 10-Q · filed 2022-10-27 | $2.07M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $30.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $27.68M 10-Q · filed 2022-08-03 | $34.97M derived: sum of 3 quarters · filed 2023-03-01 | $57.27M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$3.30M 10-Q · filed 2022-05-04 | $3.98M derived: sum of 2 quarters · filed 2023-03-01 | $26.29M derived: sum of 3 quarters · filed 2023-03-01 | -$7.01M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $7.28M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $29.59M derived: sum of 2 quarters · filed 2023-03-01 | -$3.71M derived: sum of 3 quarters · filed 2023-03-01 | $38.14M 10-K · filed 2023-03-01 |
| 2020-09-30 | $22.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$11.00M derived: sum of 2 quarters · filed 2021-11-03 | $30.86M 10-Q · filed 2021-11-03 | $43.71M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$33.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $8.55M 10-Q · filed 2021-08-05 | $21.40M derived: sum of 3 quarters · filed 2022-03-01 | $29.59M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $41.86M 10-Q · filed 2021-04-29 | $54.70M derived: sum of 2 quarters · filed 2022-03-01 | $62.89M derived: sum of 3 quarters · filed 2022-03-01 | $78.80M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $12.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $21.03M derived: sum of 2 quarters · filed 2022-03-01 | $36.95M derived: sum of 3 quarters · filed 2022-03-01 | $49.91M 10-K · filed 2022-03-01 |
| 2019-09-30 | $8.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $24.10M derived: sum of 2 quarters · filed 2020-11-05 | $37.06M 10-Q · filed 2020-11-05 | $55.94M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $15.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $28.88M 10-Q · filed 2020-08-04 | $47.75M derived: sum of 3 quarters · filed 2021-02-25 | $45.09M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $12.96M 10-Q · filed 2020-04-30 | $31.84M derived: sum of 2 quarters · filed 2021-02-25 | $29.18M derived: sum of 3 quarters · filed 2021-02-25 | $40.30M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $18.88M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $16.21M derived: sum of 2 quarters · filed 2021-02-25 | $27.34M derived: sum of 3 quarters · filed 2021-02-25 | $21.20M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$2.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $8.47M derived: sum of 2 quarters · filed 2019-11-05 | $2.33M 10-Q · filed 2019-11-05 | $13.04M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $11.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $4.99M 10-Q · filed 2019-07-31 | $15.70M derived: sum of 3 quarters · filed 2020-02-25 | $12.83M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$6.14M 10-Q · filed 2019-05-01 | $4.57M derived: sum of 2 quarters · filed 2020-02-25 | $1.71M derived: sum of 3 quarters · filed 2020-02-25 | $9.73M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $10.71M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $7.84M derived: sum of 2 quarters · filed 2020-02-25 | $15.87M derived: sum of 3 quarters · filed 2020-02-25 | $25.33M 10-K · filed 2020-02-25 |
| 2017-09-30 | -$2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $5.16M derived: sum of 2 quarters · filed 2018-11-01 | $14.63M 10-Q · filed 2018-11-01 | $17.12M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $8.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $17.49M 10-Q · filed 2018-08-01 | $19.98M derived: sum of 3 quarters · filed 2019-02-27 | $19.85M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $9.46M 10-Q · filed 2018-05-02 | $11.96M derived: sum of 2 quarters · filed 2019-02-27 | $11.82M derived: sum of 3 quarters · filed 2019-02-27 | $14.44M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $2.36M derived: sum of 2 quarters · filed 2019-02-27 | $4.98M derived: sum of 3 quarters · filed 2019-02-27 | $6.17M 10-K · filed 2019-02-27 |
| 2016-09-30 | -$135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $2.48M derived: sum of 2 quarters · filed 2017-11-01 | $3.68M 10-Q · filed 2017-11-01 | $6.26M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $3.81M 10-Q · filed 2017-08-02 | $6.40M derived: sum of 3 quarters · filed 2018-02-27 | $7.70M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $1.19M 10-Q · filed 2017-05-03 | $3.78M derived: sum of 2 quarters · filed 2018-02-27 | $5.08M derived: sum of 3 quarters · filed 2018-02-27 | $6.47M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $3.88M derived: sum of 2 quarters · filed 2018-02-27 | $5.28M derived: sum of 3 quarters · filed 2018-02-27 | $5.98M 10-K · filed 2018-02-27 |
| 2015-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $2.69M derived: sum of 2 quarters · filed 2016-11-03 | $3.40M 10-Q · filed 2016-11-03 | $4.57M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $2.10M 10-Q · filed 2016-08-04 | $3.28M derived: sum of 3 quarters · filed 2017-03-01 | $3.58M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $703.00K 10-Q · filed 2016-05-05 | $1.88M derived: sum of 2 quarters · filed 2017-03-01 | $2.18M derived: sum of 3 quarters · filed 2017-03-01 | $4.52M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.48M derived: sum of 2 quarters · filed 2017-03-01 | $3.82M derived: sum of 3 quarters · filed 2017-03-01 | $4.20M 10-K · filed 2017-03-01 |
| 2014-09-30 | $303.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $2.64M derived: sum of 2 quarters · filed 2015-11-04 | $3.02M 10-Q · filed 2015-11-04 | $2.95M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $2.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $2.72M 10-Q · filed 2015-08-06 | $2.64M derived: sum of 3 quarters · filed 2016-02-25 | $4.10M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $380.00K 10-Q · filed 2015-05-08 | $304.00K derived: sum of 2 quarters · filed 2016-02-25 | $1.76M derived: sum of 3 quarters · filed 2016-02-25 | $584.00K derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | -$76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $1.38M derived: sum of 2 quarters · filed 2016-02-25 | $204.00K derived: sum of 3 quarters · filed 2016-02-25 | $3.65M 10-K · filed 2016-02-25 |
| 2013-09-30 | $1.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $280.00K derived: sum of 2 quarters · filed 2014-11-06 | $3.72M 10-Q · filed 2014-11-06 | |
| 2013-06-30 | -$1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.27M 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | $3.44M 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |